Bio-Rad Laboratories, Inc. is a global provider of life science research and clinical diagnostic products. The company operates two segments, Life Science and Clinical Diagnostics.
Founded in 1952 by husband and wife team David and Alice Schwartz.
Introduced its first electrophoresis instrument in 1967.
Went public in 1969 and listed on the New York Stock Exchange (NYSE).
Purchased the diagnostics division of Pasteur Merieux Connaught in 1997.
Acquired the diagnostics business of Becton Dickinson in 2004.
Expanded its life sciences business with the acquisition of QuantaLife in 2011.
Continues to grow through strategic acquisitions and partnerships.
Thermo Fisher Scientific is an American company that provides scientific research services, healthcare diagnostics, and laboratory equipment.
Agilent Technologies is an American company that specializes in life sciences, diagnostics, and applied chemical markets.
Qiagen is a Dutch company that develops and produces sample and assay technologies for molecular diagnostics and life sciences research.
A digital PCR system that provides absolute quantification of nucleic acid targets for research and diagnostic applications.
Next-generation sequencing library preparation kits for targeted, whole genome, and whole transcriptome sequencing applications.
A suspension array system that enables the detection and quantification of multiple protein biomarkers in a single sample.
Bio-Rad is famous for its life science research and clinical diagnostic products.
Bio-Rad serves the life sciences and clinical diagnostics industries.
Bio-Rad has headquarters in Hercules, California, USA.
Digital PCR is a method for absolute quantification of nucleic acid targets that partitions a sample into many small droplets.
Bio-Plex assays are used for the detection and quantification of multiple protein biomarkers in a single sample for life sciences research and clinical diagnostics.